About
AstraZeneca appears at No. 102 in the 2026 Global 2000, a multi-factor ranking based on sales, profits, assets and market value. The company is headquartered in Cambridge, United Kingdom and operates primarily in drugs & biotechnology. Reported figures used for the ranking include $60.4B in sales, $10.4B in profit, $114.0B in assets and a market value of $282.1B.